Pharmaceutical News

RSS

Three vaccine candidates race to combat SARS-CoV-2

As the coronavirus disease (COVID-19) ravages across the globe, scientists are racing to develop an effective vaccine to combat the viral infection. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the disease has infected nearly 9 million people.

22 Jun 2020

New therapy provides relief in patients with chronic low back pain

A new study has found that tanezumab, a monoclonal antibody that inhibits nerve activity, provides relief in patients with chronic low back pain, one of the leading reasons why people seek medical care and the number one cause of disability worldwide.

19 Jun 2020

Researchers develop tool to identify proteins associated with drug side effects

A multi-institutional group of researchers led by Harvard Medical School and the Novartis Institutes for BioMedical Research has created an open-source machine learning tool that identifies proteins associated with drug side effects.

18 Jun 2020

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Researchers at Kessler Foundation conducted a comprehensive review of pharmacologic agents used in the treatment of multiple sclerosis, seeking evidence for efficacy for the cognitive dysfunction experienced by more than half of affected individuals.

17 Jun 2020

Early intensive treatment of rheumatoid arthritis offers an opportunity to manage fatigue

Disease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases.

17 Jun 2020

Antipsychotic medications do not treat young people with early psychosis

Researchers at Orygen have found that some young people with early stage first episode psychosis (FEP) can experience reduced symptoms and improve functioning without antipsychotic medication when they are provided with psychological interventions and comprehensive case management.

17 Jun 2020

Researchers receive federal funding to rapidly repurpose FDA-approved drugs for COVID-19

Researchers at the University of Maryland School of Medicine will be partnering on an agreement funded by the federal government's Defense Advanced Research Projects Agency (DARPA) to rapidly test hundreds of drugs, approved and marketed for other conditions, to see whether any can be repurposed to prevent or treat COVID-19.

16 Jun 2020

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.

16 Jun 2020

Apotex recalls some Metformin batches due to possible carcinogen

Metformin, a prescription drug for people with type II diabetes, helps maintain blood glucose levels. Apotex Inc., a Canadian pharmaceutical corporation, is voluntarily recalling some batches of its metformin drug, sold under the brand name APO-Metformin ER (extended-release).

15 Jun 2020

Study reveals worrying trend of designer drug use in Australia

In a sign that designer drugs are becoming more prevalent in Australia, synthetic cathinones - commonly known as 'bath salts' - have been detected in the nation's wastewater in the largest study of its kind in the country.

15 Jun 2020

Romosozumab offers considerable added benefit for postmenopausal women with osteoporosis

Romosozumab is a bone-forming monoclonal antibody used in women after menopause for the treatment of severe osteoporosis if there is a high risk of bone fractures.

15 Jun 2020

Combination of nelfinar and amodiaquine shows promise for treating COVID-19

Six months into the COVID-19 pandemic, more than 7.4 million people have been infected, and more than 410 000 have died. As yet, there is no treatment or vaccine for the disease.

15 Jun 2020

Study shows 1 in 15 parents is hesitant about routine childhood vaccines

A national study measuring parental attitudes toward vaccinations found 6.1% were hesitant about routine childhood immunizations while nearly 26% were hesitant about the influenza vaccine.

15 Jun 2020

Interferons being tested for COVID-19 may increase susceptibility to bacterial infections

Two separate studies in mice suggest that a class of interferons being evaluated in clinical trials as a therapy for COVID-19 may increase susceptibility to bacterial infections, depending on how long patients are exposed to it, and when they receive it.

12 Jun 2020

Pharmaceutical News

Three vaccine candidates race to combat SARS-CoV-2

New therapy provides relief in patients with chronic low back pain

Researchers develop tool to identify proteins associated with drug side effects

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Early intensive treatment of rheumatoid arthritis offers an opportunity to manage fatigue

Antipsychotic medications do not treat young people with early psychosis

Researchers receive federal funding to rapidly repurpose FDA-approved drugs for COVID-19

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Apotex recalls some Metformin batches due to possible carcinogen

Study reveals worrying trend of designer drug use in Australia

Romosozumab offers considerable added benefit for postmenopausal women with osteoporosis

Combination of nelfinar and amodiaquine shows promise for treating COVID-19

Study shows 1 in 15 parents is hesitant about routine childhood vaccines

Interferons being tested for COVID-19 may increase susceptibility to bacterial infections

Fentanyl tops the list of drugs detected in overdose patients at Baltimore hospitals

Aspirin reduces hereditary colorectal cancer risk

Antipsychotic drug clozapine can trigger severe obsessive-compulsive symptoms

Drug shortages can be exacerbated by COVID-19 pandemic

Researchers identify two brain phenomena that may explain the side-effects of ketamine

Hydroxychloroquine suppresses 'trained immunity'

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News